Editor-in-Chief Ufuk Demirkılıç Frequency Quarterly Abbreviation Turk J Vasc Surg Publisher Turkish National Vascular and Endovascular Surgery Society ISSN 1301 - 1839 E-ISSN 2149 - 1259


Turkish Journal of Vascular Surgery 2019 , Vol 28 , Issue 1
Elective endovascular repair of abdominal aortic aneurysms in elderly with Endologix AFX® endograft: Our short-term and one-year results
Onur Karahasanoğlu1, Veysel Başar2, Boğaçhan Bekir Akkaya1, Mehmet Hamdi Özbek1, İsa Civelek1, Mehmet Ali Kürkçü1, Ertekin Utku Ünal1, Zafer İşcan1
1Department of Cardiovascular Surgery, Türkiye Yüksek İhtisas Training and Research Hospital, Ankara, Turkey
2Department of Cardiovascular Surgery, Istanbul Kartal Koşuyolu Yüksek İhtisas Training and Research Hospital, Istanbul, Turkey
DOI : 10.9739/tjvs.2019.334 Objectives: In this study, we aimed to evaluate the performance of Endologix AFX® endografts in elderly in the early period and in the first postoperative year.

Patients and methods: Between January 2012 and December 2017, a total of 63 consecutive patients (60 males, 3 females; mean age 68.2±7.2 years; range, 52 to 84 years) with an infrarenal abdominal aortic aneurysm (AAA) were operated using endovascular aneurysm repair (EVAR) with an Endologix AFX® endograft in an elective fashion. The patients were divided into two groups as those aged under 70 years (n=35) and over 70 years of age (n=28).

Results: The most associated comorbidities were hypertension (63.5%), coronary artery disease (57.1%), and chronic obstructive pulmonary disease (38.1%). There was no 30-day mortality and no renal or cardiac morbidity in the early postoperative period. The mean length of intensive care unit stay was 9±6.4 h and the mean length of hospital stay was 3±1.4 days, indicating no statistically significant difference between the groups.

Conclusion: Our study results suggest that the Endologix AFX® endograft can yield successful outcomes in the early and postoperative first year, irrespective of the age of the patient. Keywords : Early mortality; elderly patients; Endologix AFX endograft; endovascular aneurysm repair